Rare diseases
Investigational molecules
Locations
Back to Czechia5 clinical trials in Frydek-Mistek, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
CzechiaStudy on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis
CzechiaStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
CzechiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CzechiaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical research in Frydek is focused on cardiovascular diseases, with studies exploring better ways to prevent serious heart and blood vessel complications. The main conditions under investigation are atherosclerotic cardiovascular disease and stroke prevention in atrial fibrillation.
These trials aim to improve protection against stroke, heart attack, and other serious outcomes for people at elevated cardiovascular risk.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
